Arbour Paola M, EVP and Chief Information Officer, has demonstrated a clear selling bias in recent years, with $7.25 million in total sales compared to just $91,500 in purchases across two companies—Tenet Healthcare (THC) and Texas Capital Bancshares (TCBI). The vast majority of activity centers on THC, where Arbour executed multiple high-value sales, including a $1.55 million disposition on March 11, 2026, and a $1.63 million sale on February 27, 2026. These follow earlier disposals, such as a $1.76 million transaction on March 6, 2024, and multiple six-figure sales throughout 2024 and 2025. The only recent buy was a $91,500 acquisition of TCBI shares on March 11, 2026, a rare departure from the dominant selling pattern.
The transactions suggest a strategic reduction in THC holdings, with sales occurring consistently over multiple years. Many of the dispositions were coded as "F" (sale following acquisition via a derivative transaction) or "S" (open-market sale), while the TCBI purchase was coded as "P" (open-market buy). Notably, several filings with $0 value—marked as "M" (derivative transaction) or "A" (award grant)—indicate equity-based compensation activity without immediate monetization. The data reflects a long-term trend of unwinding THC exposure while maintaining minimal activity in TCBI, aside from the recent purchase. The absence of material buys in THC reinforces the directional bias toward divestment.
AI-assisted summary